Horizon Therapeutics PLC (HZNP): Price and Financial Metrics

HZNP POWR Grades

• HZNP scores best on the Sentiment dimension, with a Sentiment rank ahead of 90.78% of US stocks.
• HZNP's strongest trending metric is Quality; it's been moving up over the last 179 days.
• HZNP ranks lowest in Momentum; there it ranks in the 8th percentile.

HZNP Stock Summary

• HZNP has a market capitalization of $24,051,085,991 -- more than approximately 89.32% of US stocks.
• HZNP's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 251.19 -- higher than 89.87% of US-listed equities with positive expected earnings growth.
• With a year-over-year growth in debt of 156.26%, Horizon Therapeutics Public Ltd Co's debt growth rate surpasses 92.91% of about US stocks.
• Stocks that are quantitatively similar to HZNP, based on their financial statements, market capitalization, and price volatility, are NICE, TRIP, STAA, TWOU, and ETSY.
• HZNP's SEC filings can be seen here. And to visit Horizon Therapeutics Public Ltd Co's official web site, go to www.horizontherapeutics.com.

HZNP Valuation Summary

• In comparison to the median Healthcare stock, HZNP's price/sales ratio is 15.42% lower, now standing at 9.6.
• HZNP's EV/EBIT ratio has moved up 65.2 over the prior 123 months.
• Over the past 123 months, HZNP's price/sales ratio has gone down 35.9.

Below are key valuation metrics over time for HZNP.

HZNP Growth Metrics

Its 5 year net cashflow from operations growth rate is now at -3.61%.
• Its 2 year net cashflow from operations growth rate is now at 54.81%.
• The 3 year net cashflow from operations growth rate now stands at -2.37%.

HZNP's revenue has moved up $2,134,048,000 over the prior 52 months.

The table below shows HZNP's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	3,226.41	1,035.271	534.491
2021-09-30	2,957.26	906.531	551.866
2021-06-30	2,556.695	604.354	518.163
2021-03-31	2,186.926	614.553	280.036
2020-12-31	2,200.429	555.688	389.796
2020-09-30	1,818.66	337.251	792.008

HZNP's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• HZNP has a Quality Grade of C, ranking ahead of 61.77% of graded US stocks.
• HZNP's asset turnover comes in at 0.385 -- ranking 123rd of 681 Pharmaceutical Products stocks.
• VNDA, NEOG, and CEMI are the stocks whose asset turnover ratios are most correlated with HZNP.

The table below shows HZNP's key quality metrics over time.